EZETIMIB Atorvast Mepha cpr pell 10mg/80mg 30 pce

7680682820078 CH-68282 C10BA05 07.12.0.

Reimbursement limitations:

ATOZET2

Le remboursement s'applique aux situations suivantes:
 - patients à haut risque, selon la catégorie de …

EZETIMIB Atorvast Mepha cpr pell 10mg/80mg 30 pce
EZETIMIB Atorvast Mepha cpr pell 10mg/80mg 30 pce
EZETIMIB Atorvast Mepha cpr pell 10mg/80mg 30 pce
1 / 3
google

Details

Product number
6828204
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
Filmtablette: ezetimibum 10 mg, atorvastatinum 80 mg ut atorvastatinum calcicum trihydricum 86.76 mg, cellulosum microcristallinum, mannitolum, calcii carbonas, carmellosum natricum conexum, hydroxypropylcellulosum, polysorbatum 80, E 172 (flavum), magnesii stearas, povidonum K 29-32, natrii laurilsulfas, Überzug: hypromellosum, talcum, E 172 (flavum), E 171, macrogolum 400, pro compresso obducto corresp. natrium 7.40 mg.

Articles (1)

Ezetimib-Atorvastatin-Mepha 10/80 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
03/10/2025
Professional SmPC
Français
03/10/2025
Professional SmPC
Italien
03/10/2025
Patient information leaflet
Allemand
07/01/2025
Patient information leaflet
Français
07/01/2025
Patient information leaflet
Italien
07/01/2025

Detailed composition

Substance Quantity Type Category
FTAB
10.0 MG Substance Wirkstoff (Principe actif)
FTAB
80.0 MG Substance Wirkstoff (Principe actif)
FTAB
86.76 MG Substance WIZUS
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FTODK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FTODK
FTAB
- Substance FNIDK
FTAB
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
FTAB
7.4 MG Substance HBESI

Reimbursement information

Public price
CHF 38.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2022

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68282
Drug name
Ezetimib-Atorvastatin-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
C10BA05
Authorization status
Z
Dispensation category
B
First authorization
28/02/2022
Authorization expiration date
27/02/2027
IT number
07.12.0.
Domain
Human medicine
Field of application
Primäre Hypercholesterinämie und Homozygote familiäre Hypercholesterinämie

Packaging details

Description (FR)
EZETIMIB Atorvast Mepha cpr pell 10mg/80mg 30 pce
Description (DE)
EZETIMIB Atorvast Mepha Filmtabl 10mg/80mg 30 Stk
Market launch
28/02/2022
Narcotic (BTM)
No

Original drug

Atozet, Filmtabletten
CHF 55.00
View original

Other packaging sizes

EZETIMIB Atorvast Mepha cpr pell 10mg/10mg 30 pce
30 TABL
View
EZETIMIB Atorvast Mepha cpr pell 10mg/10mg 90 pce
90 TABL
View
EZETIMIB Atorvast Mepha cpr pell 10mg/20mg 30 pce
30 TABL
View
EZETIMIB Atorvast Mepha cpr pell 10mg/20mg 90 pce
90 TABL
View
EZETIMIB Atorvast Mepha cpr pell 10mg/40mg 30 pce
30 TABL
View
EZETIMIB Atorvast Mepha cpr pell 10mg/40mg 90 pce
90 TABL
View
EZETIMIB Atorvast Mepha cpr pell 10mg/80mg 90 pce
90 (2 x 45) TABL
View